Pharmacopoeia reflects on permissible pharmaceutical impurities in parts per million limits

Journal Title: Journal of Drug Discovery and Therapeutics - Year 2015, Vol 3, Issue 5

Abstract

PAT (Process Analytical Technology) produces enormous amount of inorganic impurities during unit operation. Inorganic impurities are mostly ionic matters which are water soluble cations & anions. Cations are iron (Fe2+/Fe3+), arsenic (As3+/As5+), lead (Pb2+) and anions are chloride (Cl-), sulfate (SO42-). All heavy metal impurities are cumulative poison which has affinity to bind with lipid layer to produce health hazards. Pharmacopoeia says about permissible limit of each ion in parts per million (ppm) level which is acceptable by the living body with no harmful effect. This is checked by limit test which is quantitative or semi-quantitative analysis to identify the permissible impurity which is below the adverse effect. The test is generally performed by turbidity/opalescence comparison test, color comparison test and stain comparison test between test sample and standard sample. If the intensity of turbidity/colour/stain of test sample is equal to or less than standard sample then the sample passes the limit test, if the intensity of turbidity/color/stain of test sample is greater than standard sample then the sample fails to pass the limit test.

Authors and Affiliations

Neha A. Bhatt and Prof. Dr. Dhrubo Jyoti Sen| Department of Quality Assurance & Pharmaceutical Chemistry, Shri Sarvajanik Pharmacy College, Gujarat Technological University, Arvind Baug, Mehsana-384001, Gujarat, India

Keywords

Related Articles

A brief cause of acute inflammation: an overview

The inflammation is a defense biologically action on living body tissue. Acute inflammation mostly causes by bacterial infection, tissue necrosis and some chemical irritant. The visual and sign of inflammation are heat (...

GREEN CHEMISTRY AS ZERO WASTE ALLIANCE

Green chemistry consists of chemicals and chemical processes designed to reduce or eliminate negative environmental impacts. The use and production of these chemicals may involve reduced waste products, non-toxic compon...

AN OVERVIEW OF EMERGING PHARMACOLOGICAL TARGETS IN TREATMENT OF TYPE 2 DIABETES MELLITUS

Diabetes is a chronic disorder which has serious complications if not treated appropriately. A number of therapeutic agents exist for the treatment of type 2 diabetes including metformin, sulfonylureas, thiazolidinedion...

PREPARATION AND EVALUATION OF ZIDOVUDINE NANOPARTICLES

Nanoparticles represent a promising drug delivery system of controlled and targeted drug release. They are specially designed to release the drug in the vicinity of target tissue. The aim of this study was to prepare and...

REVIEW ON AN ARB HAVING HIGHER ASSOCIATION LOWER DISSOCIATION INDEX FOR A RECEPTOR: A NEW TREND IN ACHIEVEMENT OF HYPERTENSION GOAL

OLMESARTAN medoxomil (angiotensin II receptor blockers (ARBs) having blood pressure lowering efficacy similar to other antihypertensive agents. Recent large-scale, randomized, controlled clinical trials have demonstrated...

Download PDF file
  • EP ID EP1626
  • DOI -
  • Views 2506
  • Downloads 673

How To Cite

Neha A. Bhatt and Prof. Dr. Dhrubo Jyoti Sen (2015). Pharmacopoeia reflects on permissible pharmaceutical impurities in parts per million limits. Journal of Drug Discovery and Therapeutics, 3(5), 1-9. https://europub.co.uk/articles/-A-1626